BioMarin Pharmaceutical Inc. (BMRN)

111.21
2.88 2.66
NASDAQ : Health Technology
Prev Close 108.33
Open 108.34
Day Low/High 107.39 / 112.39
52 Wk Low/High 62.88 / 109.51
Volume 1.94M
Avg Volume 1.74M
Exchange NASDAQ
Shares Outstanding 180.84M
Market Cap 19.42B
EPS -0.10
P/E Ratio 170.46
Div & Yield N.A. (N.A)

Biotech, Chips Stand Their Ground

You can't help but feel better about both groups.

The 7 Pillars of Healthcare Strength

The 7 Pillars of Healthcare Strength

Here are healthcare stocks of all shares and sizes with strong charts.

Biotech Stocks at a Crossroad

Own them, or take something off the table?

Remarkable Biotech Runs Continue

Remarkable Biotech Runs Continue

A Fed-related dip may be your only hope to get in lower.

What Is Wrong With You People?

What Is Wrong With You People?

These companies are doing great -- take some profits!

Market Rewards Biotech Latecomers

It shouldn't be possible, but it never seems too late to get in.

That's Just What's Supposed to Happen

Stocks that stabilized yesterday were terrific today.

The Biotechs Are Feeling Better

The Biotechs Are Feeling Better

Sector could regain its leadership role.

The Biotechs Are Back

Watch this leadership group that's been lagging.

8 Signs the Market Is Remarkably Healthy

These are surefire indications of a bountiful tape.

Markets Lack Liquidity

Markets Lack Liquidity

Liquidity is crucial to maintaining trust in the system.

Cramer: Oil-and-Gas vs. Everything Else

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

'Top Fishing' Is the Name of the Game

Stocks, like sports, are unfair sometimes. This is one of those times.

Cramer: A Dozen Sectors to Snap Up

As 2014 winds down, you could almost throw darts at these standout groups -- but here are my own picks.

Biomarin upgraded at Wells

Resistance Is Futile

Resistance Is Futile

Here are three stock that have returned to former breakout levels.

Time to Do Some Gardening

Time to Do Some Gardening

Use the oversold bounces for trimming, cutting or hedging positions.

The Trader Daily

The Trader Daily

The focus is on all things momentum.

The Trader Daily

The Trader Daily

For Es, I believe the odds will remain in the bulls' favor.

The Trader Daily

The Trader Daily

No reason to be bearish on the SPY.

The Trader Daily

The Trader Daily

Don't sweat Wednesday's dip in the SPY.

Biomarin upgraded at Credit Suisse

The Trader Daily

The Trader Daily

The $193 level on the SPY will be key today.

The Trader Daily

The Trader Daily

Thursday's SPY trade plan will involve fading the edges,

A Tale of Diversification

A Tale of Diversification

BioMarin and Goldcorp couldn't be more different -- and similar.

Get Used to the New Market Reality

Get Used to the New Market Reality

Algos think faster and react faster than humans can.

A Blueprint for Highflier Stability

A Blueprint for Highflier Stability

Cautionary tales that the IPO window might be closing at last.

Wait for the All-Clear

Wait for the All-Clear

In other words, wait for the downgrades.